PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade
N. Srour, O. D. Villareal, Z. Yu…·S. Richard
This study shows PRMT7 inhibition enhances anti-tumor immunity and improves response to immune checkpoint blockade in melanoma by modulating immune cell infiltration and PD-L1 expression.